226
T. Abe et al. / Journal of Fluorine Chemistry 108 ꢀ2001) 215±228
3.81 ꢀs, 6H, OCH3). Analysis: Calc. for C26F20N4O4H16: C,
37.68%; F, 45.9%. Found: C, 37.7%; F, 46.0%.
p-Methoxyanilide of 38 ꢀnc): white yellow solid ꢀyield:
62%), mp 109.5±109.88C. IR ꢀNujor): 1701 [nꢀC=O)] ꢀms).
C2FNO ꢀ4.7), 69 CF3 ꢀ53.0), 57 C2FN ꢀ3.6), 50 CF2
ꢀ2.7), 47 COF ꢀ5.4).
Per¯uoro[1,4-bisꢀ3-oxacyclopentyl)piperazine] ꢀ22) ꢀnc):
bp 163.5±164.08C. MS: 603 [M À F]
ꢀ9.0), 556
ꢀ9.6), 506
19F NMR ꢀCDCl3):
d
À73.2 ꢀtriple doublet, 2F,
[M À CF2O]
ꢀ4.7), 553 [M À CF3]
JFÀF 10:4 Hz, 6.8 Hz, NCF2CFꢀCF3)CꢀO)), d À81.2 ꢀtri-
plet, 3F, JFÀF 8:8 À 10:2 Hz ,CF3CF2CF2N), d À84.4 ꢀm,
2F, NCF2CFꢀCF3)CꢀO)), d À92.3 ꢀm, 2F, CF3CF2CF2N), d
À92.7 [m, 8F, c-NꢀCF2CF2)2N], d À128.4 ꢀm, 2F,
[M À C2F4O] ꢀ36.2), 440 C9F16N2 ꢀ4.5), 295 C6F11N
ꢀ8.7), 273 C5F9NO ꢀ9.6), 264 C5F10N ꢀ17.2), 245 C5F9N
ꢀ20.1), 226 C5F8N ꢀ5.4), 214 C4F8N ꢀ10.8), 207 C5F7N
ꢀ10.7), 195 C4F7N ꢀ10.6), 176 C4F6 ꢀ14.8), 169 C3F7
ꢀ10.0), 164 C3F6N ꢀ12.4), 150 C3F6 ꢀ22.4), 145 C3F5N
ꢀ24.8), 131 C3F5 ꢀ22.9), 119 C2F5 ꢀ85.4), 114 C2F4N
1
CF3CF2CF2N), d À177.5 ꢀm, 1F, NCF2CFꢀCF3)CꢀO)), H
NMR ꢀCDCl3): d 7.88 ꢀs, 1H, NH), d 7.42 ꢀd, 2H), d 6.91 ꢀd,
2H),
d
3.82 ꢀs, 3H, OCH3). Analysis: Calc. for
C18F21N3O2H8: C, 30.99%; F, 57.3%. Found: C, 30.75; F,
ꢀ19.8), 100 C2F4 ꢀ100), 81 C2F3 ꢀ4.9), 73 C2FNO ꢀ7.2),
69 CF3 ꢀ62.1), 57 C2FN ꢀ10.6), 50 CF2 ꢀ4.8). Analysis:
Calc. for C12F22N2O2: C, 23.15%; F, 67.2%. Found: C,
23.00%; F, 67.1%.
57.0%.
3.4. Fluorination of 1,4-bis[1-methyl-2-
ꢀmethoxycarbonyl)ethyl]piperazine ꢀ4)
Per¯uoro{[3-ꢀ4-iso-propylpiperazinyl)]butyryl ¯uoride}
ꢀ23) ꢀnc): bp 173.5±174.08C. IR ꢀcapillary ®lm): 1882.4
[nꢀC=O)] ꢀms). Mass: 575 [M À F] ꢀ4.6), 425 [M À CF3]
Sample 4 ꢀ39.6 g, 0.138 mol) was ¯uorinated similarly
under the following conditions; 3.2 A/dm2, 5.5±5.6 V, 7±
88C, 611 min ꢀ223 Ah). The work-up gave the following
products in the À788C trap ꢀ10.8 g): per¯uoroꢀpropionyl
¯uoride) ꢀ4.9 g), 30 ꢀ1.6 g), 32 ꢀ2.7 g) and unidenti®ed
products ꢀ1.6 g). Cell drainings ꢀ32.9 g): 30 ꢀ1.0 g), 32
ꢀ2.0 g), 34 ꢀ1.9 g), 16 ꢀ6.2 g), per¯uoroꢀ4-ethyl-1-iso-pro-
pylpiperazine) [8] ꢀ3.1 g), per¯uoro{[3-ꢀ4-ethylpiperazi-
nyl)]butyryl ¯uoride} ꢀ25) [8] ꢀ3.2 g), per¯uoro[1-ethyl-4-
ꢀ3-oxacyclopentyl)piperazine] ꢀ26) [8] ꢀ1.7 g), per¯uoro{[3-
ꢀ4-iso-propylpiperazinyl)]butyryl ¯uoride} ꢀ23) ꢀ2.0 g),
per¯uoro[1-ꢀiso-propyl)-4-ꢀ3-oxacyclopentyl)piperazine]
ꢀ24) ꢀ1.4 g), per¯uoro{1,4-bis[1-methyl-2-ꢀ¯uorocarbony-
l)ethyl]piperazine} ꢀ20) ꢀ4.0 g), per¯uoro{3[4-ꢀ3-oxacyclo-
pentyl)piperazinyl]butyryl ¯uoride} ꢀ21) ꢀ2.7 g), per-
¯uoro[1,4-bisꢀ3-oxacyclopentyl)piperazine] ꢀ22) ꢀ0.5 g)
and unidenti®ed products ꢀ3.2 g). The GC yield of
the targeted per¯uoro{1,4-bis[1-methyl-2-ꢀ¯uorocarbonyl)-
ethyl]piperazine} ꢀ20) was only 4.7%.
ꢀ25.4), 497 [M À CF2CꢀOF] ꢀ4.5), 478 [M À C2F4O]
ꢀ8.8), 281 C5F9 ꢀ4.4), 264 C5F10N ꢀ16.7), 245 C5F9N
ꢀ9.1), 214 C4F8N ꢀ18.3), 207 C5F7N ꢀ6.3), 195 C4F7N
ꢀ3.4), 169 C3F7 ꢀ14.1), 164 C3F6N ꢀ34.6), 150 C3F6
ꢀ8.1), 145 C3F5N ꢀ10.1), 131 C3F5 ꢀ7.2), 119 C2F5 ꢀ100),
114 C2F4N ꢀ21.0), 100 C2F4 ꢀ53.4), 73 C2FNO ꢀ10.7),
69 CF3 ꢀ55.8), 50 CF2 ꢀ2.7).
Per¯uoro{[3-ꢀ4-iso-propylpiperazinyl)]oxolane} ꢀ24)
ꢀnc): bp 192.5±193.08C. Mass: 603 [M À F] ꢀ1.8), 525
[M À CF2CꢀOF] ꢀ16.0), 264 C5F10N ꢀ8.0), 214 C4F8N
ꢀ15.2), 207 C5F7N ꢀ3.8), 197 C4F7O ꢀ4.2), 195 C4F7N
ꢀ3.0), 169 C3F7 ꢀ21.2), 164 C3F6N ꢀ33.3), 150 C3F6
ꢀ8.6), 145 C3F5N ꢀ8.0), 131 C3F5 ꢀ7.7), 119 C2F5 ꢀ100),
114 C2F4N ꢀ19.2), 100 C2F4 ꢀ40.8), 73 C2FNO ꢀ4.7), 69
CF3 ꢀ53.0), 50 CF2 ꢀ2.7). Analysis: Calc. for C11F22N2O:
C, 22.22%; F, 70.4%. Found: C, 22.20%; F, 70.2%.
Methyl esters ꢀ40 from 20, 41 from 21 and 42 from 23,
respectively) of 20, 21 and 23 were prepared in a similar
manner as explained for 13.
Spectral data ꢀIR and Mass) and boiling points of 20±24
are shown below.
1,4-bis[1-tri¯uoromethyl-2-ꢀmethoxycarbonyl)tri¯uor-
oethyl]octa¯uoropiperazine ꢀ40) ꢀnc): bp 254.5±255.08C,
n2D0 1.3492, d420 1.7364. IR ꢀcapillary ®lm): 1881 [nꢀC=O)]
Per¯uoro{1,4-bis[1-methyl-2-ꢀ¯uorocarbonyl)ethyl]pi-
perazine} ꢀ20) ꢀnc): bp 199.5±199.88C. IR ꢀcapillary ®lm):
ꢀms). MS: 537 [M À CF2CꢀOOMe] ꢀ5.5), 224 C4F8N
1881.4 [nꢀC=O)] ꢀms). Mass: 603 [M À F] ꢀ1.5), 553
ꢀ8.8), 214 C4F8N ꢀ3.9), 209 CFꢀCF3)CF2CꢀO)OMe
[M À CF3] ꢀ6.6), 525 [M À CF2CꢀOF] ꢀ23.4), 264
ꢀ19.9), 207 C5F7N ꢀ10.4), 164 C3F6N ꢀ10.3), 150
C3F6 ꢀ10.4), 131 C3F5 ꢀ6.1), 119 C2F5 ꢀ13.0), 114
C5F10N ꢀ7.7), 214 C4F8N ꢀ14.6), 207 C5F7N ꢀ6.0),
197 CFꢀCF3)CꢀO)F ꢀ5.0), 169 C3F7 ꢀ26.2), 164
C2F4N ꢀ10.8), 100 C2F4 ꢀ9.7), 69 CF3 ꢀ13.8), 59
C3F6N ꢀ46.1), 150 C3F6 ꢀ4.8), 145 C3F5N ꢀ3.5), 131
CꢀO)OMe ꢀ100). Analysis: Calc. for C14F20N2O4H6: C,
C3F5 ꢀ4.0), 119 C2F5 ꢀ100), 114 C2F4N ꢀ22.8), 100
26.01%; F, 58.82%. Found: C, 25.85%; F, 59.1%.
Methyl per¯uoro{3[4-ꢀ3-oxacyclopenty)piperazinyl]bu-
tyrate} ꢀ41) ꢀnc): bp 225.0±225.58C. IR ꢀcapillary ®lm):
C2F4 ꢀ23.6), 73 C2FNO ꢀ8.5), 69 CF3 ꢀ54.3), 47 COF
ꢀ6.3).
Per¯uoro{3[4-ꢀ3-oxacyclopenty)piperazinyl]butyryl
1792 [nꢀC=O)] ꢀms). MS: 525 [M À CF2CꢀOOMe] ꢀ2.2),
¯uoride} ꢀ21) ꢀnc): bp 218.0±218.58C. IR ꢀcapillary ®lm):
214 C4F8N ꢀ3.9), 209 CFꢀCF3)CF2CꢀO)OMe ꢀ9.2), 164
C3F6N ꢀ9.7), 150 C3F6 ꢀ10.7), 145 C3F5N ꢀ5.1), 131
1882.4 [nꢀC=O)] ꢀms). MS: 603 [M À F] ꢀ1.8), 525
C3F5 ꢀ5.8), 119 C2F5 ꢀ27.8), 114 C2F4N ꢀ10.5), 100
[M À CF2CꢀOF]
ꢀ16.0), 264 C5F10N
ꢀ8.0), 214
C4F8N ꢀ15.2), 169 C3F7 ꢀ21.2), 164 C3F6N ꢀ33.3),
C2F4 ꢀ15.2), 69 CF3 ꢀ21.0), 59 CꢀO)OMe ꢀ100). Ana-
lysis: Calc. for C13F21N2O3H3: C, 24.61%; F, 62.9%. Found:
C, 24.75%; F, 63.0%.
150 C3F6 ꢀ8.6), 145 C3F5N ꢀ8.0), 131 C3F5 ꢀ7.7), 119
C2F5 ꢀ100), 114 C2F4N ꢀ19.2), 100 C2F4 ꢀ40.8), 73